Yatharth Hospital & Trauma Care Services Ltd — Fundamental Overview

Yatharth Hospital & Trauma Care Services operates a network of private multi-specialty and super-specialty hospitals in North India covering tertiary care, trauma care, and general medical services. Over FY25, it expanded bed capacity and increased utilisation across most of its hospitals. In FY25, Yatharth’s operating revenue rose about 31% year-on-year. Bed-occupancy improved to ~61% (from ~54% in FY24), while average revenue per occupied bed (ARPOB) increased by roughly 8%. Overall EBITDA rose roughly 22%, and reported net profit increased ~14% compared to the previous fiscal. The company ended FY25 with a net cash balance — long-term debt is negligible — giving it a clean balance sheet and financial flexibility. Business-wise, Yatharth’s strength lies in expanding capacity and steadily improving occupancy and realizations, especially at its larger hospitals. It benefits if demand for quality private healthcare remains strong, and as more beds come online, economies of scale and higher utilization could further improve margins. However, there are risks. Hospital business remains capital-intensive; depreciation and operating costs rise sharply with every new facility. If occupancy or average billings falter, profitability can drop. Also, the hospital sector tends to have low visibility — patient inflows, regulatory changes, and cost pressures are hard to predict. In summary: Yatharth is a growth-oriented healthcare play, with improving fundamentals, clean finances, and expansion potential. It’s not a “safe dividend payer,” but for a medium-to-long-term investor comfortable with cyclicality and execution risk, it offers credible upside.